Nature of Disclosure: Regulatory filing pursuant to Regulation 30 read with Para B of Part A of Schedule III of SEBI Listing Regulations, intimating the allotment of equity shares under an Employee Stock Option Plan (ESOP).

Key Event: The Nomination and Remuneration Committee (NRC) of Renaissance Global Limited, via a Circular Resolution passed on June 19, 2026, approved the allotment of 34,590 fully paid-up equity shares of face value ₹2 each to grantees who exercised their vested options under the "Renaissance Global – Employee Stock Option Scheme 2021" (RGL ESOP 2021).

Details of Allotment:

  • Number of shares allotted: 34,590
  • Face value per share: ₹2
  • The allotted shares are fully paid-up and will rank pari-passu with the existing equity shares of the company in all respects.
  • The company will apply for the listing of these 34,590 equity shares on the National Stock Exchange of India Limited (NSE) and BSE Limited.

Capital Structure Impact:

Consequent to this allotment, the company's paid-up equity share capital has increased:

  • Pre-allotment capital: ₹21,46,67,762 comprising 10,73,33,881 equity shares of ₹2 each.
  • Post-allotment capital: ₹21,47,36,942 comprising 10,73,68,471 equity shares of ₹2 each.

ESOP Scheme Details (From Annexure-1):

  • Total Scheme Size: The RGL ESOP 2021 covers a total of 25,00,000 stock options, each convertible into one equity share.
  • Grant Details: Options have been granted across seven grants (Grant-1 to Grant-7), totaling 20,28,702 options.
  • Pricing Formula: Options under Grant-1, Grant-2, and Grant-3 are exercisable at ₹110 each. Options under Grant-4, Grant-5, Grant-6, and Grant-7 are exercisable at ₹2 each.
  • Options Exercised: 34,590 options were exercised in this tranche.
  • Money Realized: The exercise of options realized ₹13,20,900 for the company.
  • Options Lapsed: 53,570 options under Grant-6 lapsed due to non-acceptance by the grantee.
  • Diluted EPS Impact: The issuance of shares on exercise of options results in a diluted earnings per share (EPS) of ₹0.72.
  • Vesting & Exercise Window: Vested options can be exercised within 3 years from their respective vesting dates.

Specifics of Current Allotment (From Annexure-2):

  • Date of Allotment: June 19, 2026
  • Distinctive Numbers: Shares allotted bear distinctive numbers from 10,73,33,882 to 10,73,68,471 (both inclusive).
  • Exercise Price Breakdown: 11,590 options were exercised at ₹110 per share, and 23,000 options were exercised at ₹2 per share.
  • Premium: A premium of ₹108 per share was realized on the 11,590 shares exercised at ₹110 (face value ₹2). No premium was realized on the 23,000 shares exercised at ₹2.
  • Lock-in: No lock-in is applicable on the allotted shares.

Regulatory Compliance:

The disclosure is made as required under:

1. Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Circular dated July 13, 2023 (Annexure-1).

2. Regulation 10(c) of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 (Annexure-2).

The scheme was previously approved by shareholders via a postal ballot concluded on January 21, 2022.